生命倫理と保険事業 : 遺伝子情報と保険に関する研究会の活動報告を中心に  [in Japanese] Bioethics and Life Insurance Business : Focusing on the Report of Activities of the Study Group on Genetic Information and Life Insurance  [in Japanese]

Search this Article

Author(s)

Abstract

遺伝子検査と危険選択を巡る議論が,マスコミを含め取上げられる機会が多くなってきている。また先端医療の進歩に伴う様々な生命倫理の問題に対しても保険業界は真撃に取り組まねばならなくなってきている。本稿では,3年前にあった「遺伝子情報と生命保険に関する研究会」の活動の経緯を報告し,その際纏められた遺伝子情報と生命保険に関する学会の見解表明と遺伝子検査と危険選択を巡る諸問題の解説資料を原文のまま掲載することとした。残念ながら当時諸事情のため公開することには至らなかったが,本稿が遺伝子情報と生命保険を巡る議論の資料となることを信じて,今回学会長の了解のもと投稿させていただいた。

Arguments over the genetic testing and risk selection are increasingly taken up at every opportunity including the mass media. The life insurance industry has come earnestly to tackle all sorts of problems of bioethics with the advance of high-tech medical treatment. In this paper, I report the details of activities of "the study group on the genetic information and life insurance" which was set up three years ago, and dare to carry the originals of the statement of the Association of Insurance Medicine of Japan regarding the genetic information and life insurance and the explanatory material for various problems concerning the genetic testing and risk selection that were organized on that occasion. Unfortunately, they were not opened to the public due to circumstances at the time; however, believing that this paper will result in the material for arguments over the genetic information and life insurance.

Journal

  • The journal of the Association of Life Insurance Medicine of Japan

    The journal of the Association of Life Insurance Medicine of Japan 101(3), 273-303, 2003-09-17

    The Association of Insuramce Medicine of Japan

References:  24

Cited by:  1

Codes

  • NII Article ID (NAID)
    110004697928
  • NII NACSIS-CAT ID (NCID)
    AN00197853
  • Text Lang
    JPN
  • Article Type
    Journal Article
  • ISSN
    0301262X
  • Data Source
    CJP  CJPref  NII-ELS 
Page Top